Article
Biochemistry & Molecular Biology
Mastaneh Safarnejad Shad, Sandra Claes, Eline Goffin, Tom Van Loy, Dominique Schols, Steven De Jonghe, Wim Dehaen
Summary: The expansion of the structure-activity relationship study of CXCR4 antagonists led to the synthesis of a series of isoquinolines with excellent activity, among which compound 24c showed consistently low nanomolar activity in various assays and was deemed the most promising.
Article
Pharmacology & Pharmacy
Isabel Hamshaw, Marco M. D. Cominetti, Wing-Yee Lai, Mark Searcey, Anja Mueller
Summary: Cancer metastasis is a major cause of cancer-related death. The CXCR4 receptor and its ligand CXCL12 play important roles in promoting metastasis, making them attractive therapeutic targets. In this study, a novel CXCR4 antagonist was developed and used for CXCR4-based imaging. The results showed that these antagonists were non-toxic and effectively inhibited cancer cell migration and calcium release.
BIOCHEMICAL PHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Francesca Curreli, Young D. Kwon, Isabella Nicolau, Giancarla Burgos, Andrea Altieri, Alexander V. Kurkin, Raffaello Verardi, Peter D. Kwong, Asim K. Debnath
Summary: As part of the effort to discover drugs targeting HIV-1 entry, this study investigates the antiviral activity and crystal structures of two novel inhibitors in complex with a gp120 core. The results show that NBD-14204 exhibits better antiviral activity and sensitivity to certain mutants, making it a promising compound for further optimization.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Immunology
Sara Moron-Lopez, Silvia Bernal, Joseph K. Wong, Javier Martinez-Picado, Steven A. Yukl
Summary: ABX464 has a significant effect on the HIV reservoir and transcription profile, decreasing total HIV DNA and HIV transcriptional initiation, and possibly decreasing intact HIV DNA and HIV transcriptional elongation.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Chemistry, Multidisciplinary
Dipankar Chaudhuri, Tiangong Lu, Binu Jacob, Sojan Abraham, Premlata Shankar, Michael A. Poss, Nouri Neamati, Julio A. Camarero
Summary: The CXCR4 chemokine is a crucial regulator of leukocyte functions, embryonic development, and cancer progression. CXCR4 antagonists show promise as therapeutic agents for cancer and HIV. This study shows that lipidation can improve the half-life of a bioactive cyclotide antagonist, but the choice of lipid may affect its biological activity.
JOURNAL OF CONTROLLED RELEASE
(2023)
Article
Oncology
Lisa Marie Kaiser, Mirja Harms, Daniel Sauter, Vijay P. S. Rawat, Mirco Glitscher, Eberhard Hildt, Daniel Tews, Zachary Hunter, Jan Muench, Christian Buske
Summary: Waldenstrom's Macroglobulinemia is a B-cell lymphoma with aggressive disease in patients with CXCR4 mutations. A natural peptide called EPIX4 and its derivatives have shown to impair lymphoma cell growth, indicating potential novel therapies in Waldenstrom's Macroglobulinemia.
Article
Environmental Sciences
Jakub Trawinski, Michas Wronski, Robert Skibinski
Summary: This study presented the photochemical transformation of the antiretroviral drug maraviroc under simulated UV-Vis radiation. The drug showed high photo-resistance and had a half-life over 250 h, but degradation rate increased when natural river water matrix was added. A photocatalytic method using titanium dioxide and peroxymonosulfate was proposed to eliminate maraviroc, greatly accelerating the degradation process. Majority of the photoproducts identified were still present after termination of irradiation, indicating the need for ecotoxicological assessment.
JOURNAL OF ENVIRONMENTAL MANAGEMENT
(2022)
Article
Oncology
Tomokatsu Kato, Yoichi Matsuo, Goro Ueda, Hiromichi Murase, Yoshinaga Aoyama, Kan Omi, Yuichi Hayashi, Hiroyuki Imafuji, Kenta Saito, Mamoru Morimoto, Ryo Ogawa, Hiroki Takahashi, Shuji Takiguchi
Summary: The study found that CXCR4 is highly expressed in radiation-resistant PaCa cells, and the CXCL12/CXCR4 axis may be involved in the radiation resistance of PaCa. Treatment with a CXCR4 antagonist can suppress the invasion ability of radiation-resistant PaCa cells, aiding in the inhibition of cell colonization.
Article
Chemistry, Medicinal
Angela Corona, Sebastian Seibt, David Schaller, Rainer Schobert, Andrea Volkamer, Bernhard Biersack, Enzo Tramontano
Summary: The bioactive components of Garcinia indica, garcinol and isogarcinol, show potential as drug candidates for treating various human diseases. Garcinol demonstrated higher HIV-1-RNase H inhibition compared to a known inhibitor, while isogarcinol was less active, emphasizing the importance of the enolizable beta-diketone moiety in garcinol for anti-RNase H activity. Docking calculations supported these findings, suggesting the involvement of this moiety in chelating metal ions of the enzyme's active site.
ARCHIV DER PHARMAZIE
(2021)
Article
Pharmacology & Pharmacy
Mirja Harms, Monica M. W. Habib, Simona Nemska, Antonella Nicolo, Andrea Gilg, Nico Preising, Pandian Sokkar, Sara Carmignani, Martina Raasholm, Gilbert Weidinger, Goenuel Kizilsavas, Manfred Wagner, Ludger Staendker, Ashraf H. Abadi, Hassan Jumaa, Frank Kirchhoff, Nelly Frossard, Elsa Sanchez-Garcia, Jan Muench
Summary: The EPI-X4 derivative JM#21 is a novel potent CXCR4 antagonist that shows therapeutic efficacy in atopic dermatitis and has demonstrated effectiveness in treating CXCR4-associated diseases, especially in asthma and other inflammatory conditions.
ACTA PHARMACEUTICA SINICA B
(2021)
Review
Cell Biology
Gary D. Luker, Jinming Yang, Ann Richmond, Stefania Scala, Claudio Festuccia, Margret Schottelius, Hans-Jurgen Wester, Johann Zimmermann
Summary: Signaling through CXCR4 regulates essential physiological processes and plays crucial roles in tumor growth, invasion, and metastasis. Animal models consistently demonstrate the importance of CXCR4 in cancer initiation and progression.
JOURNAL OF LEUKOCYTE BIOLOGY
(2021)
Review
Cell Biology
Mohd Ishtiaq Anasir, Faisal Zarif, Chit Laa Poh
Summary: Enteroviruses (EV) from the Picornaviridae family are known to cause diseases such as hand foot and mouth disease, respiratory diseases, encephalitis and myocarditis. Developing small molecules that target the capsid of EV for viral entry interference has faced challenges such as low efficacy, off-target effects, and resistance. Peptides derived from the capsid of EV that recognize cellular receptors have shown potential as host-targeting inhibitors, but they exhibit lower potency compared to small molecule compounds. Further research on structure-based design of antiviral peptides is needed to uncover more potent options for treating EV infections.
JOURNAL OF BIOMEDICAL SCIENCE
(2021)
Article
Biochemical Research Methods
C. N. Prashantha, K. Gouthami, L. Lavanya, Sivaramireddy Bhavanam, Ajay Jakhar, R. G. Shakthiraju, V. Suraj, K. V. Sahana, H. S. Sujana, N. M. Guruprasad, R. Ramachandra
Summary: Research on COVID-19 has shown that HIV protease inhibitors, anti-inflammatory drugs, and antibiotics have high affinity for the spike protein, making them potential lead drug molecules for treatment against the virus.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING
(2021)
Article
Biochemistry & Molecular Biology
Natasha Marques Cassani, Igor Andrade Santos, Victoria Riquena Grosche, Giulia Magalhaes Ferreira, Marco Guevara-Vega, Rafael Borges Rosa, Lindomar Jose Pena, Nilson Nicolau-Junior, Adelia Cristina Oliveira Cintra, Tiago Patriarca Mineo, Robinson Sabino -Silva, Suely Vilela Sampaio, Ana Carolina Gomes Jardim
Summary: This study demonstrates that two phospholipases A2 (PLA2) isolated from snake venom can inhibit the activity of Zika virus, with a strong effect on the entry of the virus into host cells. These findings suggest that these PLA2s could serve as potential templates for the development of antiviral drugs against Zika virus in the future.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2023)
Article
Biochemistry & Molecular Biology
Yingying Liang, Sevin Turcan
Summary: Epigenetic drugs have been used in the treatment of hematologic malignancies, and their potential in solid tumors is still being investigated. Current evidence suggests that these drugs may enhance antitumor immunity by increasing antigen presentation and improving the therapeutic effect of immune checkpoint inhibitors.
Article
Biochemistry & Molecular Biology
Mariana Valerio, Diogo A. Mendonca, Joao Morais, Carolina C. Buga, Carlos H. Cruz, Miguel A. R. B. Castanho, Manuel N. Melo, Claudio M. Soares, Ana Salome Veiga, Diana Lousa
Summary: The fusion peptide (PIFP) of the parainfluenza virus plays an important role in membrane fusion by inducing the formation of a porelike structure and facilitating fusion. Depending on the PIFP/lipid ratio, it can also lead to membrane leakage.
ACS CHEMICAL BIOLOGY
(2022)
Article
Virology
Alexandra Tauzin, Gabrielle Gendron-Lepage, Manon Nayrac, Sai Priya Anand, Catherine Bourassa, Halima Medjahed, Guillaume Goyette, Mathieu Dube, Renee Bazin, Daniel E. Kaufmann, Andres Finzi
Summary: SARS-CoV-2 infection leads to a gradual decline in antibody levels, but an increase in antibody avidity, which is correlated with B cell class switch. Similar increase in antibody avidity is observed after SARS-CoV-2 mRNA vaccination. Avidity determination of anti-RBD IgG could serve as a surrogate assay for antibody affinity maturation in studying humoral responses elicited by natural infection and/or vaccination.
Article
Medicine, Research & Experimental
Jacinta O. Pinho, Mariana Matias, Vanda Marques, Carla Eleuterio, Celia Fernandes, Lurdes Gano, Joana D. Amaral, Eduarda Mendes, Maria Jesus Perry, Jao Nuno Moreira, Gert Storm, Ana Paula Francisco, Cecilia M. P. Rodrigues, M. Manuela Gaspar
Summary: Researchers synthesized a new hybrid molecule that showed remarkable antiproliferative activity against melanoma by specifically activating tyrosinase. They also demonstrated that incorporating the molecule into long blood circulating liposomes allowed for passive targeting of tumor sites, leading to high therapeutic efficacy.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Immunology
Alexandra Tauzin, Mehdi Benlarbi, Halima Medjahed, Yves Gregoire, Josee Perreault, Gabrielle Gendron-Lepage, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Cecile Tremblay, Daniel E. Kaufmann, Valerie Martel-Laferriere, Ines Levade, Marceline Cote, Gaston De Serres, Renee Bazin, Andres Finzi
Summary: The Omicron BQ.1.1 variant has become the dominant strain of SARS-CoV-2 in many countries. Due to the extensive mutations in its Spike glycoprotein, this variant is resistant to the immune responses induced by single-dose mRNA vaccines. To enhance immune responses against Omicron subvariants, bivalent mRNA vaccines have been approved in several countries. This study demonstrates that a fourth dose of mono- or bivalent mRNA vaccine improves the recognition and neutralization of the ancestral Spike, and individuals with recent infections show better recognition and neutralization of the BQ.1.1 Spike, regardless of the mRNA vaccine used, compared to those without recent infections.
Article
Biotechnology & Applied Microbiology
Sofia A. Martins, Joana Santos, Sandra Cabo Verde, Joao D. G. Correia, Rita Melo
Summary: Virus-like particles (VLPs) are self-assembling nanoplatforms that can be used as carriers for vaccines, drug delivery, or imaging agents. This study presents early results on the production and characterization of HIV-1-based VLPs, which have the potential to serve as non-toxic tools for drug and/or imaging agent transport.
BIOENGINEERING-BASEL
(2022)
Editorial Material
Biochemistry & Molecular Biology
Nuno Taveira
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Nuno Taveira, Ines Figueiredo, Rita Calado, Francisco Martin, Ines Bartolo, Jose M. Marcelino, Pedro Borrego, Fernando Cardoso, Helena Barroso
Summary: Developing immunogens that can elicit broadly neutralizing antibodies (bNAbs) is crucial for the development of an effective HIV vaccine. In this study, a prime-boost vaccination strategy using vaccinia virus expressing the gp120 envelope glycoprotein of HIV-2 and a polypeptide comprising specific regions of the envelope glycoprotein was shown to elicit bNAbs against both HIV-1 and HIV-2. The findings suggest that a chimeric envelope glycoprotein containing specific regions from both viruses could be a potential vaccine immunogen to target neutralizing epitopes in both HIV-1 and HIV-2.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Biochemistry & Molecular Biology
Ines Moranguinho, Nuno Taveira, Ines Bartolo
Summary: Currently, an estimated 1-2 million people worldwide are infected with HIV-2, comprising 3-5% of the global HIV burden. While HIV-2 infection has a longer course compared to HIV-1, a significant number of infected individuals will progress to AIDS and die without effective antiretroviral therapy (ART). Unfortunately, many of the antiretroviral drugs currently in use were designed for HIV-1 and do not work as well, or not at all, against HIV-2. This review discusses the available therapeutic options for treating HIV-2-infected patients, including both existing drugs and promising drugs in development, as well as the emergence of drug resistance mutations and resistance pathways in HIV-2-infected patients under treatment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Virology
Guillaume Beaudoin-Bussieres, Alexandra Tauzin, Katrina Dionne, Gabrielle Gendron-Lepage, Halima Medjahed, Josee Perreault, Ines Levade, Laila Alfadhli, Yuxia Bo, Renee Bazin, Marceline Cote, Andres Finzi
Summary: Since the start of the SARS-CoV-2 pandemic, multiple variants of concern (VOCs) like Alpha, Beta, Gamma, Delta, and Omicron have emerged and spread globally. Currently, the predominant circulating subvariants are different lineages of the Omicron variant, which possess over 30 mutations in their Spike glycoprotein compared to the original strain. These Omicron subvariants are significantly less recognized and neutralized by antibodies from vaccinated individuals, leading to a surge in infections. Booster shots are recommended to enhance immune responses against these variants.
Article
Multidisciplinary Sciences
Ana S. Andre, Joana N. R. Dias, Sandra Aguiar, Sara Nogueira, Pedro Bule, Joana Ines Carvalho, Joao P. M. Antonio, Marco Cavaco, Vera Neves, Soraia Oliveira, Goncalo Vicente, Belmira Carrapico, Berta Sao Braz, Barbara Ruetgen, Lurdes Gano, Joao D. G. Correia, Miguel Castanho, Joao Goncalves, Pedro M. P. Gois, Solange Gil, Luis Tavares, Frederico Aires-da-Silva
Summary: Antibody-drug conjugates (ADCs) are a rapidly growing therapeutic class in oncology, but they face significant engineering challenges. To develop more stable and effective ADCs, researchers explored the potential of rabbit-derived VL-single-domain antibody scaffolds (sdAbs) to selectively conjugate a payload to Cys80.
SCIENTIFIC REPORTS
(2023)
Article
Medicine, General & Internal
Mariana Anselmo Assuncao, Joao Botelho, Vanessa Machado, Luis Proenca, Antonio P. A. Matos, Jose Joao Mendes, Lucinda J. J. Bessa, Nuno Taveira, Alexandre Santos
Summary: Dental implants are the preferred method for replacing lost teeth. This study compared the effectiveness of electrolytic decontamination, erythritol jet system, and titanium brushes in removing Pseudomonas aeruginosa biofilms from dental implants, and evaluated the changes in the implant surface. The results showed that electrolytic decontamination, erythritol-chlorhexidine particle jet system, and i-Brush brushing had similar performance in removing P. aeruginosa biofilm. However, titanium brushes caused significant changes to the implant surface, which need further evaluation.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Chemistry, Inorganic & Nuclear
Leon F. Richter, Fernanda Marques, Joao D. G. Correia, Alexander Poethig, Fritz E. Kuehn
Summary: The synthesis of a homoleptic azide-functionalised Au(I) bis-1,2,3-triazole-5-ylidene complex is reported, demonstrating the efficient modification ability and steric shielding superiority of the presented triazole ligand framework in click-chemistry protocols. The complex exhibits high antiproliferative activity in A2780 and MCF-7 human cancer cells.
DALTON TRANSACTIONS
(2023)